Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,648
Closed -$201K 182
2026
Q1
$201K Sell
3,648
-4,188
-53% -$227K 0.1% 160
2025
Q4
$384K Sell
7,836
-94
-1% -$4.38K 0.21% 102
2025
Q3
$372K Sell
7,930
-976
-11% -$38.1K 0.22% 100
2025
Q2
$342K Sell
8,906
-949
-10% -$36.3K 0.24% 99
2025
Q1
$393K Sell
9,855
-3,329
-25% -$122K 0.34% 81
2024
Q4
$465K Buy
+13,184
New +$475K 0.4% 66

Other funds holding GSK

Brucke Financial's GSK Position: Q2 2026 in Review

Brucke Financial sold out of GSK (GSK) in Q2 2026, closing a stake of 3,648 shares — an estimated $201K sold.

Brucke Financial first reported a position in GSK in Q4 2024 and held it in 6 quarters. The position peaked at $465K in Q4 2024. 396 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Brucke Financial reported no remaining GSK position as of Q2 2026 after selling out during the quarter.
  • Brucke Financial sold 3,648 GSK shares in Q2 2026, an estimated $201K.
  • Brucke Financial first reported a position in GSK in Q4 2024 and held it in 6 quarters.
  • Brucke Financial's GSK position peaked at $465K in Q4 2024.
  • 396 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Brucke Financial's 13F filing for Q2 2026, filed 21 Jul 2026.